Dr. Ram Yogendra

Yeah, you know what happens? When you submit a journal, it goes through this plagiarism check, right? So it'll say, oh, 70% of your paper or 80% is plagiarized. Well, we got this thing back saying, well, this entire section is plagiarized. Well, that's because we applied the same exact materials and methods from the long COVID paper. We're the same group that was published the paper.

Yeah, you know what happens? When you submit a journal, it goes through this plagiarism check, right? So it'll say, oh, 70% of your paper or 80% is plagiarized. Well, we got this thing back saying, well, this entire section is plagiarized. Well, that's because we applied the same exact materials and methods from the long COVID paper. We're the same group that was published the paper.

So it actually got four out of five stars.

So it actually got four out of five stars.

Yeah, you know, I think obviously there's a lot of focus right now on Dr. Fauci and his role in COVID and the response to COVID and, you know, with all the stuff going on in Wuhan and the gain-of-function research and all that going on. But I think the role of Dr. Collins here should also be scrutinized. And that's coming from a personal experience because, you know, our work was ignored.

Yeah, you know, I think obviously there's a lot of focus right now on Dr. Fauci and his role in COVID and the response to COVID and, you know, with all the stuff going on in Wuhan and the gain-of-function research and all that going on. But I think the role of Dr. Collins here should also be scrutinized. And that's coming from a personal experience because, you know, our work was ignored.

And I don't know the reason why. Maybe he was busy or maybe someone can ask him. But, you know, this is this is not this is public information. This was on a congressional hearing. And I posted this on my Twitter page where Congressman Doyle is literally bringing us up in our research. And we had some correspondence with him.

And I don't know the reason why. Maybe he was busy or maybe someone can ask him. But, you know, this is this is not this is public information. This was on a congressional hearing. And I posted this on my Twitter page where Congressman Doyle is literally bringing us up in our research. And we had some correspondence with him.

And then afterwards, we were ghosted, ghosted by the letter organizations by.

And then afterwards, we were ghosted, ghosted by the letter organizations by.

The FDA, NIH, and we didn't engage with the CDC, but it was the NIH and the FDA because we said, look, we found this. I had Brian, he's our lab tech. I said, listen, store the blood because if the FDA scientists or the NIH scientists want to examine these patients' blood, we'll coordinate that and get this over to them. And maybe they can do further studies because

The FDA, NIH, and we didn't engage with the CDC, but it was the NIH and the FDA because we said, look, we found this. I had Brian, he's our lab tech. I said, listen, store the blood because if the FDA scientists or the NIH scientists want to examine these patients' blood, we'll coordinate that and get this over to them. And maybe they can do further studies because

You know, quite frankly, even with our research and what we found, there's still a lot of unanswered questions in our findings. So if we had the help back in 2021, I think we might have helped millions of people that have been suffering from these COVID vaccines. It's true.

You know, quite frankly, even with our research and what we found, there's still a lot of unanswered questions in our findings. So if we had the help back in 2021, I think we might have helped millions of people that have been suffering from these COVID vaccines. It's true.

Yeah, so we're trying to get the paper published. Um, now they're hit pieces coming against, uh, Bruce and I, um, we're getting doxed, uh, death threats. Uh, you know, we got, I got a call.

Yeah, so we're trying to get the paper published. Um, now they're hit pieces coming against, uh, Bruce and I, um, we're getting doxed, uh, death threats. Uh, you know, we got, I got a call.

Yeah. Death threats. Um, Bruce got a lot of death threats on his, uh, on his business line at the lab. Uh, people are scared to go to work. You know, some of our credibility is being mirrored all over the place because, you know, quite frankly, we were looking at an uncomfortable topic, and that's the post-COVID vaccine syndrome or the vaccine injuries. So I'm trying to get the paper published.

Yeah. Death threats. Um, Bruce got a lot of death threats on his, uh, on his business line at the lab. Uh, people are scared to go to work. You know, some of our credibility is being mirrored all over the place because, you know, quite frankly, we were looking at an uncomfortable topic, and that's the post-COVID vaccine syndrome or the vaccine injuries. So I'm trying to get the paper published.

Multiple journals are rejecting. They're not even letting the paper into peer review, just publicly. But at the same time, we've got this preprint, we're going around discussing this and people are going, well, it's not peer reviewed. Well, I can't get it into peer review because they're not accepting it. And here's the other challenge behind this.

Multiple journals are rejecting. They're not even letting the paper into peer review, just publicly. But at the same time, we've got this preprint, we're going around discussing this and people are going, well, it's not peer reviewed. Well, I can't get it into peer review because they're not accepting it. And here's the other challenge behind this.